Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.
NCT00422955
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuropathy, Diabetic
Interventions
DRUG:
rosiglitazone
Sponsor
GlaxoSmithKline